CG Oncology, Inc. (CGON) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $752.60M | +2.6% |
| 2024 | $733.38M | +695.8% |
| 2023 | -$123.10M | -58.4% |
| 2022 | -$77.69M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $752.60M | +2.6% |
| 2024 | $733.38M | +695.8% |
| 2023 | -$123.10M | -58.4% |
| 2022 | -$77.69M | — |